|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net (loss) income | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Amortization and depreciation | |||||
| Issuance cost in relation to warrant | |||||
| Change in fair value of warrant liability | |||||
| Share-based compensation | |||||
| Loss on investments in marketable securities, net | |||||
| Unrealized loss (gain) from fair value change of the long-term investments, net | |||||
| Impairment loss of long-term investment | |||||
| Impairment loss of long-term investment | |||||
| (Gain) loss on disposal of long-lived assets | |||||
| Loss on disposal of long-lived assets | |||||
| Impairment loss on long-lived assets | |||||
| Allowance for credit loss of due from a related party | |||||
| Write-off of prepayment and other receivables | |||||
| Write-off of accounts receivable | |||||
| Write-down of inventories | |||||
| Gain on disposal of subsidiaries | |||||
| Amortization of right-of-use assets | |||||
| Interest expense and accretion of convertible debts | |||||
| Reversal of deferred cash bonus | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other receivables and prepayments | |||||
| Long-term deposits | |||||
| Due from brokers | |||||
| Amounts due from related parties | |||||
| Amounts due to related parties | |||||
| Accounts payable and accrued expenses | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from disposal of property and equipment | |||||
| Proceeds from sales of investment securities | |||||
| Loan to a related party | |||||
| Repayment of loan and interest from a related party | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Loan from related parties | |||||
| Proceeds from issuance of Class A Ordinary Shares and warrant | |||||
| Exercise of share options | |||||
| Payments related to offering costs | |||||
| Repayment of bank loan | |||||
| Proceeds from issuance of convertible notes | |||||
| Proceeds from issuance of Class A Ordinary Shares | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents – Beginning of year | |||||
| Cash and cash equivalents – End of year | |||||
| Supplemental disclosures of cash flow information | |||||
| Interest paid | |||||
| Non-cash operating, investing and financing activities | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Reclassification of placement agent warrant redemption amount | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Convertible notes converted to Class A Ordinary Shares | |||||
| Cash and cash equivalents | |||||
| Settlement of deferred cash bonus by issuance of share options | |||||
Loading...